Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
By altering the components of the vaccine regimen, researchers drove promising antibody and immune-cell responses.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
A major trial has closed down after the experimental vaccine failed both to prevent HIV transmission and to reduce viral load in those who con...
Researchers shuttered a trial after the experimental vaccine failed to both prevent HIV transmission and to reduce viral load in those contrac...
An investigatory vaccine from the Baltimore-based Profectus BioSciences is both safe in humans and prompts an immune response to HIV proteins.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.